MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number AFAPRO28 |
Device Problems
Material Integrity Problem (2978); Protective Measures Problem (3015)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/01/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Continuation of d10: product id 203cx (lot: 226053122); product type: 0627-cables and accessories; implant date n/a; explant date n/a product id 106e2 (serial: (b)(6); product type: 0628-console <(>&<)> spare parts; implant date n/a; explant date n/a medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that during a cryo ablation procedure, after the deflation of the balloon catheter an unknown system notice occurred indicating the catheter has detected fluid and stopped injection.The balloon catheter and the coaxial umbilical cable were replaced and another system notice occurred saying that there is a problem with refrigerant port.Blood was reported on the tip of the coaxial umbilical cable and the console coaxial port on the console. the case was completed with cryo.The binary files were corrupted and could not be transferred.A field service visit took place at a later time.The console was serviced appropriately. no patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Product event summary: the data files and the afapro28 balloon catheter with lot 20019 number were returned and analyzed.No patient file was received.The received failure file contained failure records for the date of the event.The failure file showed the following persistent system notices on the reported date of the event, system notice 50005 (the safety system has detected fluid in the catheter and stopped the injection; system notice 50024 (there is a problem with the refrigerant port); system notice 50002 (the system has detected an electrical component failure); system notice 50013 (the refrigerant level is too low to continue); system notice 50028 (there is a problem with the injection process).External visual inspection of the balloon segment showed blood/fluid inside the balloon.The catheter smart chip data was downloaded and reviewed.Data indicated the catheter was used for eleven applications on the reported event date.During functional testing, the console terminated the application and triggered system notice 50005 (th e safety system detected fluid in the catheter and stopped the injection).During pressure testing of the balloon segment, a double-balloon breach condition was identified.Dissection did not show any signs of lifted thermocouple wires or leak detection wires that could have caused the breach.In conclusion, the reported visible blood issue was confirmed and the returned balloon catheter failed the returned product inspection due to a double balloon breach.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|